Findings

What do systematic reviews say?

3 questions · 3 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 3 · 100%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin plus isoniazid changes active TB compared with isoniazid (very low certainty).

1 finding from 1 review

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin changes active TB compared with isoniazid (very low certainty).

1 finding from 1 review

Active TB · HIV‐negative people at risk of TB infection1

It is very uncertain whether rifampicin plus pyrazinamide changes active TB: compared with isoniazid (very low certainty).

1 finding from 1 review